Cyteir Therapeutics, Inc.
CYT · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $58,200 | $400,096 | $415,691 | $338,145 |
| - Cash | $147,120 | $189,723 | $10,938 | $29,012 |
| + Debt | $889 | $0 | $0 | $0 |
| Enterprise Value | -$88,031 | $210,373 | $404,753 | $309,133 |
| Revenue | $0 | $0 | $0 | $8 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$1,375 | -$479 | -$351 | -$5 |
| % Margin | – | – | – | -58.6% |
| EBITDA | -$46,061 | -$41,780 | -$20,592 | -$15,890 |
| % Margin | – | – | – | -198,625% |
| Net Income | -$43,952 | -$41,647 | -$20,823 | -$15,044 |
| % Margin | – | – | – | -188,050% |
| EPS Diluted | -1.25 | -1.18 | -0.87 | -0.77 |
| % Growth | -5.9% | -35.6% | -13% | – |
| Operating Cash Flow | -$42,532 | -$36,032 | -$18,539 | -$17,557 |
| Capital Expenditures | -$312 | -$1,189 | -$850 | -$133 |
| Free Cash Flow | -$42,844 | -$37,221 | -$19,389 | -$17,690 |